James W. Edinger - Belford NJ, US Aleksandar Francki - Annandale NJ, US Aleksandr Kaplunovsky - Budd Lake NJ, US Vladimir Jankovic - New York NY, US Kristen Labazzo - Springfield NJ, US Eric Law - East Brunswick NJ, US Neerav Padliya - Scotch Plains NJ, US Jennifer Paredes - Bloomfield NJ, US Jia-Lun Wang - Cherry Hill NJ, US
Assignee:
Anthrogenesis Corporation - Warren NJ
International Classification:
A61K 35/50
US Classification:
424 937
Abstract:
Provided herein are novel angiogenic cells from amnion, referred to as amnion derived adherent cells, and populations of, and compositions comprising, such cells. Further provided herein are methods of obtaining such cells and methods of using the cells in the treatment of individuals.
- Warren NJ, US James W. Edinger - Belford NJ, US Aleksandar Francki - Annandale NJ, US Aleksandr Kaplunovsky - Budd Lake NJ, US Vladimir Jankovic - New York NY, US Kristen Labazzo - Springfield NJ, US Eric Law - East Brunswick NJ, US Neerav Padliya - Scotch Plains NJ, US Jennifer Paredes - Bloomfield NJ, US Jia-Lun Wang - Kendall Park NJ, US
Assignee:
ANTHROGENESIS CORPORATION - Warren NJ
International Classification:
A61K 35/50
Abstract:
Provided herein are novel angiogenic cells from amnion, referred to as amnion derived adherent cells, and populations of, and compositions comprising, such cells. Further provided herein are methods of obtaining such cells and methods of using the cells in the treatment of individuals.
- Warren NJ, US James W. Edinger - Belford NJ, US Aleksandar Francki - Annandale NJ, US Robert J. Hariri - Bernardsville NJ, US Vladimir Jankovic - New York NY, US Aleksandr Kaplunovsky - Budd Lake NJ, US Kristen Labazzo - Springfield NJ, US Eric Law - East Brunswick NJ, US Neerav D. Padliya - Scotch Plains NJ, US Jennifer Paredes - Bloomfield NJ, US Jia-Lun Wang - Kendall Park NJ, US
Assignee:
ANTHROGENESIS CORPORATION - Warren NJ
International Classification:
A61K 35/50 A61L 27/38 C12N 5/073 A61K 35/28
Abstract:
Provided herein are methods of treating individuals having diseases or disorders of the circulatory system, using placental cells, e.g., the placental stem cells and placental multipotent cells (PDACs) described herein, and populations of such placental cells. The invention also provides methods of angiogenesis using such cells or populations of cells comprising such cells.